H.I.G.-GPII Inc. 13D and 13G filings for Clarus Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-21 4:18 pm Purchase |
2021-09-09 | 13D | Clarus Therapeutics Holdings, Inc. CRXTQ |
H.I.G.-GPII Inc. | 5,692,381 26.200% |
5,692,381 (New Position) |
Filing |